Hedia Appoints International Pharma Profile Carl Bilbo as New Chairperson
Hedia Appoints International Pharma Profile Carl Bilbo as New Chairperson June 3, 2024 Hedia is pleased to announce the appointment of Carl Bilbo as its new chairperson. Carl brings extensive international experience from the pharmaceutical industry, combining strong commercial expertise with a deep scientific understanding of diabetes. His leadership will be key as Hedia continues […]
Hedia Joined Danish Royal State Visit to France
Hedia Joined Danish Royal State Visit to France Copenhagen, Denmark – April 25, 2025 – Hedia is proud to have participated in the historic Danish Royal State Visit to France as part of the official business delegation accompanying Their Majesties King Frederik X and Queen Mary of Denmark. The visit, which took place from March […]
Hedia Launches Clinical Study in France to Optimize Type 1 Diabetes Management
Hedia Launches Major Clinical Study in France to Evaluate its Digital Therapy (DTx) for Type 1 Diabetes Management March 31, 2025 Copenhagen, Denmark – March 31, 2025 – Hedia, a Danish company developing digital therapies (DTx) to optimize diabetes management, announces the launch of a clinical study in France to evaluate the impact of its […]
Hedia appoints new CEO
Hedia appoints new CEO February 20, 2024 Lars has a strong track record of scaling market leading global MedTech companies. Prior to joining Hedia Lars was Senior Vice President in 3Shape (3D scanners and CAD/CAM software solutions) where he was on the senior leadership team with global responsibility for several commercial functions and earlier 5 […]
Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing
Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and Palo Alto, CA, USA, January 8th, 2025 Glooko, Inc. and Hedia, today announced the launch of their interoperable solution, which combines […]
Hedia brings in a new CCO from MedTech industry
Hedia brings in a new CCO from MedTech industry Hedia continues to strengthen the company’s commercial competences ahead of the launch of a new and updated version of the Hedia Diabetes Assistant in England, Sweden and France, and brings in Julia Abrams, former GM Northwest Europe and SVP Diagnostics at Siemens Healthineers. Hedia stands strong […]
Hedia Appoints New Board Member from the Pharmaceutical Industry
Hedia Appoints New Board Member from the Pharmaceutical Industry Hedia continues to strengthen its commercial expertise ahead of launching an updated version of the Hedia Diabetes Assistant in the UK and Sweden. The company has welcomed Kamilla Enggaard Have, the Managing Director of Jazz Pharmaceuticals Nordics, to its board. With a newly acquired MDR certification […]
Hedia and Glooko reveal new global partnership
Hedia and Glooko reveal new global partnership We have been looking forward to revealing our new global partnership with Glooko. By integrating our diabetes assistant into Glooko’s diabetes management platform for healthcare providers and people with diabetes, the collaboration will provide a solution that brings together connected care, remote patient monitoring, and digital therapeutic technologies. […]
ForaCare and Hedia: A new strategic collaboration
ForaCare and Hedia: A new strategic collaboration We are happy to announce our new collaboration with ForaCare Suisse AG. By combining ForaCare’s expertise in glucose monitoring devices and our diabetes management app, the goal is to provide an integrated solution for diabetes management. Check out all the details on the good news herehttps://www.foracare.ch/news/foracare-announces-collaboration-with-hedia/ Read More […]
Hedia to Showcase Improvements in Glycaemic Control of T1D users at ATTD
Hedia to Showcase Improvements in Glycaemic Control of T1D users at ATTD Hedia, which is developing digital therapeutics for insulin-requiring diabetes, is announcing its participation in the scientific program of Advanced Technologies & Treatments for Diabetes (ATTD). At the conference, Hedia will present the retrospective study which investigated if type 1 diabetes (T1D) users of […]